Product Information

METHYLPHENIDATE 5 MG TABLET is a generic product labeled by Ascend Laboratories, LLC, priced at $0.1190 per EA under NDC 67877061601. Its NADAC has been published 273 times since Sep 1, 2021.

FDA first approved this application on Oct 4, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

METHYLPHENIDATE 5 MG TABLET

Methylphenidate Hydrochloride
$0.1190per EA
DEA Schedule CII

Strength

5 mg/1

NDC

67877061601

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA211779

FDA Approved

10/4/2019

TE Code

AB

On Market Since

10/6/2019

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulation

Price Statistics

The NADAC for METHYLPHENIDATE 5 MG TABLET has been published 273 times since Sep 1, 2021, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$0.1190 per EA
All-time high$0.1434 (Feb 11, 2026)
All-time low$0.0841 (Jul 17, 2024)
52-week high$0.1434
52-week low$0.1190
Median price$0.1152
Average price$0.1169
Largest weekly change+55.5% (Aug 21, 2024)
Weeks tracked273
Tracking sinceSep 1, 2021

Price History

1W

-2.3%

1M

-6.2%

3M

-9.1%

6M

-12.3%

1Y

-14.2%

3Y

+7.5%

5Y

+10.1%

All

-0.6%

Generic Alternatives

The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 28% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of METHYLPHENIDATE 5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for METHYLPHENIDATE 5 MG TABLET, manufactured by Ascend Laboratories, LLC, is $0.1190 per EA (NDC 67877061601), effective Nov 18, 2026.

How has the price of METHYLPHENIDATE 5 MG TABLET changed over time?

Over the history we have for it, the NADAC for METHYLPHENIDATE 5 MG TABLET has held within roughly two percent of its current level. It has been tracked across 273 weekly CMS publications since Sep 1, 2021.

What are the highest and lowest recorded NADAC prices for METHYLPHENIDATE 5 MG TABLET?

Since Sep 1, 2021, the NADAC for METHYLPHENIDATE 5 MG TABLET has ranged from a low of $0.0841 (Jul 17, 2024) to a high of $0.1434 (Feb 11, 2026), with a median of $0.1152 per EA.

Are there cheaper alternatives to METHYLPHENIDATE 5 MG TABLET?

Yes. 7 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, METHYLPHENIDATE 5 MG TABLET, is $0.0858 per EA — about 28% below METHYLPHENIDATE 5 MG TABLET.

Who manufactures METHYLPHENIDATE 5 MG TABLET?

METHYLPHENIDATE 5 MG TABLET (NDC 67877061601) is labeled by Ascend Laboratories, LLC, and CMS classifies it as a generic product.